MX9401415A - Ligandos 5-ht1a. - Google Patents

Ligandos 5-ht1a.

Info

Publication number
MX9401415A
MX9401415A MX9401415A MX9401415A MX9401415A MX 9401415 A MX9401415 A MX 9401415A MX 9401415 A MX9401415 A MX 9401415A MX 9401415 A MX9401415 A MX 9401415A MX 9401415 A MX9401415 A MX 9401415A
Authority
MX
Mexico
Prior art keywords
ht1a
leagues
radiolabelled
pet
studies
Prior art date
Application number
MX9401415A
Other languages
English (en)
Inventor
Ian Anthony Cliffe
Allan Fletcher
Alan Chapman White
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of MX9401415A publication Critical patent/MX9401415A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0468Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describen antagonistas de 5-HT1A selectivos, radiomarcados con H3 o C11 que son ligandos radiomarcados útiles, por ejemplo, en procedimientos de selección farmacológica y en estudios de tomografía de emisión de positrones (PET).
MX9401415A 1993-02-26 1994-02-24 Ligandos 5-ht1a. MX9401415A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939303968A GB9303968D0 (en) 1993-02-26 1993-02-26 5-ht1a ligands

Publications (1)

Publication Number Publication Date
MX9401415A true MX9401415A (es) 1994-08-31

Family

ID=10731124

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9401415A MX9401415A (es) 1993-02-26 1994-02-24 Ligandos 5-ht1a.

Country Status (12)

Country Link
US (1) US6056942A (es)
EP (1) EP0686047B1 (es)
AT (1) ATE188614T1 (es)
AU (1) AU6009694A (es)
DE (1) DE69422611T2 (es)
DK (1) DK0686047T3 (es)
ES (1) ES2141819T3 (es)
GB (1) GB9303968D0 (es)
GR (1) GR3032479T3 (es)
MX (1) MX9401415A (es)
PT (1) PT686047E (es)
WO (1) WO1994019026A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9413772D0 (en) * 1994-07-08 1994-08-24 Wyeth John & Brother Ltd 5-HT1A ligands
RU2268725C2 (ru) * 2000-01-19 2006-01-27 Акцо Нобель Н.В. Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств
CA2455981C (en) 2001-08-09 2012-10-09 Joan Baptista Urgell Beltran Use of cationic surfactants in cosmetic preparations
MXPA04001169A (es) * 2001-08-09 2005-02-17 Miret Lab Nuevos sistemas de conservacion y su uso en preparaciones cosmeticas.
MXPA04003855A (es) 2001-10-25 2004-07-08 Miret Lab Uso de consevadores cationicos en productos alimenticios.
BRPI0208457B1 (pt) 2002-02-01 2015-06-16 Miret Lab Processo para a preparação de um éster de n(alfa)-acil-l-arginina derivado de ácidos graxos e aminoácidos dibásicos esterificados
DE60223598T2 (de) 2002-05-08 2008-03-06 Laboratorios Miret, S.A., Les Fonts-Terrassa Neue konservierungsmittel und konservierungssysteme
JP4730760B2 (ja) * 2004-05-25 2011-07-20 住友重機械工業株式会社 Ri標識化合物合成システム
US7731940B2 (en) 2006-01-25 2010-06-08 The Regents Of The University Of California Compositions and methods related to serotonin 5-HT1A receptors
WO2011150183A1 (en) 2010-05-28 2011-12-01 Ge Healthcare Limited Radiolabeled compounds and methods thereof
GB201112987D0 (en) 2011-07-28 2011-09-14 Ge Healthcare Ltd Novel compound
GB201116359D0 (en) * 2011-09-22 2011-11-02 Ge Healthcare Ltd Novel synthesis method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0173310B1 (ko) * 1989-04-22 1999-02-01 폴 에이 리쳐 피페라진 유도체
ATE187718T1 (de) * 1989-04-22 2000-01-15 American Home Prod Tertiäre alkyl funktionalisierte piperazin- derivate
US4994258A (en) * 1990-03-05 1991-02-19 Merck & Co., Inc. Gamma emitting, CCK-A antagonists for pancreatic imaging
GB9022820D0 (en) * 1990-10-19 1990-12-05 Wyeth John & Brother Ltd Piperazine derivatives
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives

Also Published As

Publication number Publication date
EP0686047A1 (en) 1995-12-13
PT686047E (pt) 2000-06-30
ATE188614T1 (de) 2000-01-15
GR3032479T3 (en) 2000-05-31
GB9303968D0 (en) 1993-04-14
WO1994019026A1 (en) 1994-09-01
DK0686047T3 (da) 2000-04-25
EP0686047B1 (en) 2000-01-12
AU6009694A (en) 1994-09-14
DE69422611D1 (de) 2000-02-17
DE69422611T2 (de) 2008-10-09
ES2141819T3 (es) 2000-04-01
US6056942A (en) 2000-05-02

Similar Documents

Publication Publication Date Title
DE59914576D1 (de) Computertomographie-Verfahren mit kegelförmigen Strahlenbündel, und Computertomograph
MX9401415A (es) Ligandos 5-ht1a.
ES2174895T3 (es) Combinaciones metalicas complejas con contenido en carbenos heterociclicos.
ATE249460T1 (de) 1,4-diazabicyclo(3.2.2)nonanderivate, deren herstellung und deren verwendung in heilkunde
FI896093A0 (fi) Varmlaminerbara, gas ogenomslaeppliga flerskiktsfolier.
DE68923763D1 (de) Anordnung von Datenzellen und Aufbau von Neuronennetzen, die eine solche Anordnung nutzen.
FI83346B (fi) Kalander, saerskilt en superkalander.
DE68909416D1 (de) Radiotherapeutische immunokonjugate, etikettiert mit iod-125.
DE69015564D1 (de) Vollverdiefte verbindungsstruktur mit titanium/wolfram und selektivem cvd-wolfram.
FI892753A0 (fi) Hoejdregleringsanordning foer armstoed pao stolar, saerskilt rullstolar.
Prakash et al. Drain-2DX, Drain-3DX and Drain-building: base program design documentation
DE3851869D1 (de) Tetraindolyl-heptamethin-ether, -alkohole und Farbstoffe.
FI880819A0 (fi) Smaeltugn och foerfarande foer matning av det material, som behandlas in i den.
AT380497B (de) Gleisbaumaschine mit siebanlage fuer schuettgut, schotter und dgl.
FR2707369B1 (fr) Réservoir, en particulier, du type bouteille à gaz.
IT8963230V0 (it) Coclea tranciante, particolarmente per materiali filamentosi, collaborante con mezzi di taglio particolarment conformati e posizionati.
DE58907546D1 (de) Substituierte Naphthacen-5,12-dione und deren Verwendung.
FI891049A0 (fi) En eller flera lockfoersedda oeppningar i arbetspaln, i synnerhet diskbaenk i koek.
DE3764040D1 (de) 1,4-distryrylbenzolverbindungen und deren mischungen mit anderen 1,4-distryrylbenzolverbindungen.
FI904661A0 (fi) Substituerade azoler, deras framstaellning, formulering och anvaendning som fungicider.
IT8721850A0 (it) Dispositivo per raddrizzare fili di trama deformati obliquamente e, oppure ad arco nel tessuto.
NL189755C (nl) Goederenwagon, met buiten de buitenste langsdragers uitstekende kopbalken en aftilbare gesloten wagenbak.
IT8322617V0 (it) Mobili bar, in particolare per uffici e piccole comunita'.
DE58904067D1 (de) Fahrzeug, wie einsatzfahrzeug.
NO883533L (no) Kutterring for tunnelboring i fjell.